STRATA CRITICAL MEDICAL, INC. Proceeds from Sale and Maturity of Held-to-maturity Securities
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Proceeds from Sale and Maturity of Held-to-maturity Securities of $30.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2026-03-31 was $30.50M, a 71.69% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2025-12-31 was $23.20M, a 144.21% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2025-09-30 was $51.70M, a 20.72% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. proceeds from sale and maturity of held-to-maturity securities for fiscal 2025 was $226.20M, a 27.47% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. proceeds from sale and maturity of held-to-maturity securities for fiscal 2024 was $177.45M, a 32.92% decline from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. proceeds from sale and maturity of held-to-maturity securities for fiscal 2023 was $264.54M, a 169.94% increase from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. proceeds from sale and maturity of held-to-maturity securities for fiscal 2022 was $98.00M.
| Period end | Proceeds from Sale and Maturity of Held-to-maturity Securities 3 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 6 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 9 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $30.50M 10-Q · filed 2026-08-04 | $53.70M derived: sum of 3 quarters · filed 2026-08-04 | $105.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $30.50M 10-Q · filed 2026-05-06 | $53.70M derived: sum of 2 quarters · filed 2026-05-06 | $105.40M derived: sum of 3 quarters · filed 2026-05-06 | $148.95M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $23.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $74.90M derived: sum of 2 quarters · filed 2026-03-03 | $118.45M derived: sum of 3 quarters · filed 2026-08-04 | $226.20M 10-K · filed 2026-03-03 |
| 2025-09-30 | $51.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $95.25M derived: sum of 2 quarters · filed 2026-08-04 | $203.00M 10-Q · filed 2025-11-10 | $212.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $43.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $151.30M 10-Q · filed 2026-08-04 | $160.80M derived: sum of 3 quarters · filed 2026-08-04 | $226.01M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $107.75M 10-Q · filed 2026-05-06 | $117.25M derived: sum of 2 quarters · filed 2026-05-06 | $182.46M derived: sum of 3 quarters · filed 2026-05-06 | $182.46M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $74.71M derived: sum of 2 quarters · filed 2026-03-03 | $74.71M derived: sum of 3 quarters · filed 2026-03-03 | $177.45M 10-K · filed 2026-03-03 |
| 2024-09-30 | $65.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $65.21M derived: sum of 2 quarters · filed 2025-11-10 | $167.95M 10-Q · filed 2025-11-10 | $167.95M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $102.74M 10-Q · filed 2025-08-05 | $102.74M derived: sum of 3 quarters · filed 2025-08-05 | $236.09M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $102.74M 10-Q · filed 2025-05-12 | $102.74M derived: sum of 2 quarters · filed 2025-05-12 | $236.09M derived: sum of 3 quarters · filed 2025-05-12 | $236.09M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $133.35M derived: sum of 2 quarters · filed 2025-03-13 | $133.35M derived: sum of 3 quarters · filed 2025-03-13 | $264.54M 10-K · filed 2025-03-13 |
| 2023-09-30 | $133.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $133.35M derived: sum of 2 quarters · filed 2024-11-12 | $264.54M 10-Q · filed 2024-11-12 | $342.54M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $131.19M 10-Q · filed 2024-08-08 | $209.19M derived: sum of 3 quarters · filed 2024-08-08 | $229.19M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $131.19M 10-Q · filed 2024-05-07 | $209.19M derived: sum of 2 quarters · filed 2024-05-07 | $229.19M derived: sum of 3 quarters · filed 2024-05-07 | $229.19M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $98.00M derived: sum of 2 quarters · filed 2024-03-12 | $98.00M derived: sum of 3 quarters · filed 2024-03-12 | $98.00M 10-K · filed 2024-03-12 |
| 2022-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $20.00M derived: sum of 2 quarters · filed 2023-11-08 | $20.00M 10-Q · filed 2023-11-08 | $20.00M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $0.00 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |